´Ù¹ß¼º°æÈ­Áõ°ú ´Ù¸¥ Å»¼öÃʼº Áúȯ¿¡¼­ÀÇ ½Å°æ¾È°úÀû ¼Ò°ß
Neuro-Ophthalmology in Multiple Sclerosis and Other Demyelinating Disease

´ëÇѾȽŰæÀÇÇÐȸÁö 2014³â 4±Ç 1È£ p.22 ~ p.26

°­ºÀÈñ(Kang Bong-Hui) - ´Ü±¹´ëÇб³ Àǰú´ëÇÐ ½Å°æ°úÇб³½Ç
±èÀçÀÏ(Kim Jae-Il) - ´Ü±¹´ëÇб³ Àǰú´ëÇÐ ½Å°æ°úÇб³½Ç

Abstract

This review summarized the most relevant articles from the field of neuro-ophthalmology in multiple sclerosis and other demyelinating disease. Multiple sclerosis and neuromyelitis optica spectrum disorder are commonly manifested by afferent and efferent visual pathway and that may initially present with ophthalmologic symptoms. Recognizing these syndromes and signs will help clinicians to properly evaluate the patient, formulate an appropriate differential diagnosis, be able to discuss the prognosis with the patient, and help develop an effective therapeutic plan.

Ű¿öµå

Neuro-ophthalmology, Multiple sclerosis, Neuromyelitis optica, Optic neuritis, Efferent ocular manifestations
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå